Savara (SVRA) Return on Sales (2013 - 2022)
Savara (SVRA) reported Return on Sales of 413.68% for Q1 2022, down 24195.75% quarter-over-quarter from 1.7% in Q4 2021.
Savara (SVRA) Return on Sales (2013 - 2022) Analysis & Trends
Savara (SVRA) has 8 years of Return on Sales data on file, last reported at 413.68% in Q1 2022.
- Return on Sales for Q1 2022 came in at 413.68%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was 413.68% (changed N/A YoY), and the FY2020 annual result was 1.98%, changed N/A from the prior year.
- Return on Sales declined to 413.68% in Q1 2022 per SVRA's latest filing, from 1.7% in the prior quarter.
- Over five years, Return on Sales peaked at 0.44% in Q3 2020 and troughed at 413.68% in Q1 2022.
- A 3-year average of 110.61% and a median of 1.79% in 2021 frame the typical range for Return on Sales.
- On a YoY basis, Return on Sales climbed as much as 13372 bps in 2021 and fell as far as 135 bps in 2021.
- A 3-year view of Return on Sales shows it stood at 135.42% in 2020, then surged by 99 bps to 1.7% in 2021, then sank by 24196 bps to 413.68% in 2022.
- Business Quant data shows SVRA's Return on Sales at 413.68% in Q1 2022, 1.7% in Q4 2021, and 1.79% in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -413.68% |
| Dec 31, 2021 | -1.70% |
| Sep 30, 2021 | -1.79% |
| Dec 31, 2020 | -135.42% |
| Sep 30, 2020 | -0.44% |
| Sep 30, 2017 | -0.65% |
| Jun 30, 2017 | 1.22% |
| Mar 31, 2017 | -0.53% |
| Dec 31, 2016 | -0.07% |
| Sep 30, 2016 | -0.72% |
| Jun 30, 2016 | -4.87% |
| Mar 31, 2016 | -6.37% |
| Dec 31, 2015 | -2.25% |
| Mar 31, 2014 | -0.45% |
| Dec 31, 2013 | -0.24% |
| Jun 30, 2013 | -0.10% |
| Mar 31, 2013 | -0.14% |